CAFS 2013:Ensite Velocity系统在持续性房颤的消融治疗中的应用

2013-08-01 蒋晨阳 MedSci原创

    Ensite Velocity系统的高密度标测功能在持续性房颤的消融治疗中有较独特的优势,与以往的三维标测系统相比,Ensite Velocity系统的高密度标测功能(High Density Mapping, HDM)在持续性房颤消融中的特点,可以用三个字概括,即:准、精和快。具体如下:1)准,即准确。能在三维模型表面的定义范围内(如定义为离表面距离

    Ensite Velocity系统的高密度标测功能在持续性房颤的消融治疗中有较独特的优势,与以往的三维标测系统相比,Ensite Velocity系统的高密度标测功能(High Density Mapping, HDM)在持续性房颤消融中的特点,可以用三个字概括,即:准、精和快。具体如下:1)准,即准确。能在三维模型表面的定义范围内(如定义为离表面距离 3、5mm等)记录电位大小、激动顺序等,既可排除远场干扰,又能排除贴靠过紧导致的模型变形和电位失真;2)精,即精确。选用的多极标测电极(如:十级 或二十极等),由于它们电极较窄、极间距较短,显示的信号分辨率高,能精确地捕捉微弱电信号;3)快,即快速。由于是多电极同时标测(如:十级或二十极 等),能快速密集标测,数分钟内即可完成整个心腔的标测。

Ensite Velocity系统的“one model”功能

    Ensite Velocity系统的 one model功能充分体现了人性化,使过去数个步骤的标测一次就能完成,因此能较高程度地满足复杂电生理手术的需要,特别是房颤术后的房速标测的需要,简化 了手术过程。one model能做到一边建模,一边获取局部电信号的各种信息(电压、局部激动时间等),能显著缩短标测的时间,进而缩短整个手术时间。我作为临床一线的医 生,对电生理新技术和新工具的不断推陈出新感到欣喜。

EnSite Velocity心脏三维标测系统能清晰迅速地标测心脏的解剖结构

  Ensite Velocity系统左房建模比较真实、准确和细腻,能将肺静脉、前庭和左房以及左心耳之间的关系建得非常清楚,就像一张栩栩如生的油画。这归功于以下技 术的进步:1)全新的建模计算公式,减少了假腔的形成;2)有效的呼吸补偿功能,基本解决了以往清醒镇静下消融呼吸补偿不足导致模型移位的难题。我国许多 电生理中心采用清醒镇静下手术的方式,因此该系统比较适应我国国情。当然该系统也有缺点,即放置参考电极导管需要一定的技巧。若忽视或没有掌握这一点,参 考电极容易移位,最后导致模型移位。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1738453, encodeId=63931e38453d5, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4763, encryptionId=a9dd4e63c4, topicName=CIT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eabf34462441, createdName=12498877m109暂无昵称, createdTime=Tue Apr 15 15:10:00 CST 2014, time=2014-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2007548, encodeId=3b1c200e548cf, content=<a href='/topic/show?id=930139e38e' target=_blank style='color:#2F92EE;'>#CAF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3973, encryptionId=930139e38e, topicName=CAF)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Tue Oct 01 09:10:00 CST 2013, time=2013-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1922517, encodeId=73bb192251ecb, content=<a href='/topic/show?id=3f3156324ff' target=_blank style='color:#2F92EE;'>#持续性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56324, encryptionId=3f3156324ff, topicName=持续性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c31495, createdName=liuyg0228, createdTime=Mon Jan 13 00:10:00 CST 2014, time=2014-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941525, encodeId=62f71941525ed, content=<a href='/topic/show?id=64c94e75a3' target=_blank style='color:#2F92EE;'>#City#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4775, encryptionId=64c94e75a3, topicName=City)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cd7162, createdName=nakerunner, createdTime=Sat May 10 12:10:00 CST 2014, time=2014-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1910455, encodeId=dd8319104557d, content=<a href='/topic/show?id=faf7163606a' target=_blank style='color:#2F92EE;'>#SIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16360, encryptionId=faf7163606a, topicName=SIT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Fri Feb 07 18:10:00 CST 2014, time=2014-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1722977, encodeId=02711e22977ca, content=<a href='/topic/show?id=a43d39e48d' target=_blank style='color:#2F92EE;'>#CAFS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3974, encryptionId=a43d39e48d, topicName=CAFS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c42133335789, createdName=wleon8906, createdTime=Tue Mar 18 06:10:00 CST 2014, time=2014-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421572, encodeId=69a414215e2e8, content=<a href='/topic/show?id=4bc865819d2' target=_blank style='color:#2F92EE;'>#消融#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65819, encryptionId=4bc865819d2, topicName=消融)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a193676008, createdName=xiangyuzhou972, createdTime=Sat Aug 03 02:10:00 CST 2013, time=2013-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597706, encodeId=00d3159e706db, content=<a href='/topic/show?id=28986582e02' target=_blank style='color:#2F92EE;'>#消融治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65827, encryptionId=28986582e02, topicName=消融治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f07818523366, createdName=zhishijing, createdTime=Sat Aug 03 02:10:00 CST 2013, time=2013-08-03, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1738453, encodeId=63931e38453d5, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4763, encryptionId=a9dd4e63c4, topicName=CIT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eabf34462441, createdName=12498877m109暂无昵称, createdTime=Tue Apr 15 15:10:00 CST 2014, time=2014-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2007548, encodeId=3b1c200e548cf, content=<a href='/topic/show?id=930139e38e' target=_blank style='color:#2F92EE;'>#CAF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3973, encryptionId=930139e38e, topicName=CAF)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Tue Oct 01 09:10:00 CST 2013, time=2013-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1922517, encodeId=73bb192251ecb, content=<a href='/topic/show?id=3f3156324ff' target=_blank style='color:#2F92EE;'>#持续性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56324, encryptionId=3f3156324ff, topicName=持续性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c31495, createdName=liuyg0228, createdTime=Mon Jan 13 00:10:00 CST 2014, time=2014-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941525, encodeId=62f71941525ed, content=<a href='/topic/show?id=64c94e75a3' target=_blank style='color:#2F92EE;'>#City#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4775, encryptionId=64c94e75a3, topicName=City)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cd7162, createdName=nakerunner, createdTime=Sat May 10 12:10:00 CST 2014, time=2014-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1910455, encodeId=dd8319104557d, content=<a href='/topic/show?id=faf7163606a' target=_blank style='color:#2F92EE;'>#SIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16360, encryptionId=faf7163606a, topicName=SIT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Fri Feb 07 18:10:00 CST 2014, time=2014-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1722977, encodeId=02711e22977ca, content=<a href='/topic/show?id=a43d39e48d' target=_blank style='color:#2F92EE;'>#CAFS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3974, encryptionId=a43d39e48d, topicName=CAFS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c42133335789, createdName=wleon8906, createdTime=Tue Mar 18 06:10:00 CST 2014, time=2014-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421572, encodeId=69a414215e2e8, content=<a href='/topic/show?id=4bc865819d2' target=_blank style='color:#2F92EE;'>#消融#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65819, encryptionId=4bc865819d2, topicName=消融)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a193676008, createdName=xiangyuzhou972, createdTime=Sat Aug 03 02:10:00 CST 2013, time=2013-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597706, encodeId=00d3159e706db, content=<a href='/topic/show?id=28986582e02' target=_blank style='color:#2F92EE;'>#消融治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65827, encryptionId=28986582e02, topicName=消融治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f07818523366, createdName=zhishijing, createdTime=Sat Aug 03 02:10:00 CST 2013, time=2013-08-03, status=1, ipAttribution=)]
    2013-10-01 lvliquan
  3. [GetPortalCommentsPageByObjectIdResponse(id=1738453, encodeId=63931e38453d5, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4763, encryptionId=a9dd4e63c4, topicName=CIT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eabf34462441, createdName=12498877m109暂无昵称, createdTime=Tue Apr 15 15:10:00 CST 2014, time=2014-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2007548, encodeId=3b1c200e548cf, content=<a href='/topic/show?id=930139e38e' target=_blank style='color:#2F92EE;'>#CAF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3973, encryptionId=930139e38e, topicName=CAF)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Tue Oct 01 09:10:00 CST 2013, time=2013-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1922517, encodeId=73bb192251ecb, content=<a href='/topic/show?id=3f3156324ff' target=_blank style='color:#2F92EE;'>#持续性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56324, encryptionId=3f3156324ff, topicName=持续性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c31495, createdName=liuyg0228, createdTime=Mon Jan 13 00:10:00 CST 2014, time=2014-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941525, encodeId=62f71941525ed, content=<a href='/topic/show?id=64c94e75a3' target=_blank style='color:#2F92EE;'>#City#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4775, encryptionId=64c94e75a3, topicName=City)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cd7162, createdName=nakerunner, createdTime=Sat May 10 12:10:00 CST 2014, time=2014-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1910455, encodeId=dd8319104557d, content=<a href='/topic/show?id=faf7163606a' target=_blank style='color:#2F92EE;'>#SIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16360, encryptionId=faf7163606a, topicName=SIT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Fri Feb 07 18:10:00 CST 2014, time=2014-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1722977, encodeId=02711e22977ca, content=<a href='/topic/show?id=a43d39e48d' target=_blank style='color:#2F92EE;'>#CAFS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3974, encryptionId=a43d39e48d, topicName=CAFS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c42133335789, createdName=wleon8906, createdTime=Tue Mar 18 06:10:00 CST 2014, time=2014-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421572, encodeId=69a414215e2e8, content=<a href='/topic/show?id=4bc865819d2' target=_blank style='color:#2F92EE;'>#消融#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65819, encryptionId=4bc865819d2, topicName=消融)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a193676008, createdName=xiangyuzhou972, createdTime=Sat Aug 03 02:10:00 CST 2013, time=2013-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597706, encodeId=00d3159e706db, content=<a href='/topic/show?id=28986582e02' target=_blank style='color:#2F92EE;'>#消融治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65827, encryptionId=28986582e02, topicName=消融治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f07818523366, createdName=zhishijing, createdTime=Sat Aug 03 02:10:00 CST 2013, time=2013-08-03, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1738453, encodeId=63931e38453d5, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4763, encryptionId=a9dd4e63c4, topicName=CIT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eabf34462441, createdName=12498877m109暂无昵称, createdTime=Tue Apr 15 15:10:00 CST 2014, time=2014-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2007548, encodeId=3b1c200e548cf, content=<a href='/topic/show?id=930139e38e' target=_blank style='color:#2F92EE;'>#CAF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3973, encryptionId=930139e38e, topicName=CAF)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Tue Oct 01 09:10:00 CST 2013, time=2013-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1922517, encodeId=73bb192251ecb, content=<a href='/topic/show?id=3f3156324ff' target=_blank style='color:#2F92EE;'>#持续性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56324, encryptionId=3f3156324ff, topicName=持续性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c31495, createdName=liuyg0228, createdTime=Mon Jan 13 00:10:00 CST 2014, time=2014-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941525, encodeId=62f71941525ed, content=<a href='/topic/show?id=64c94e75a3' target=_blank style='color:#2F92EE;'>#City#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4775, encryptionId=64c94e75a3, topicName=City)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cd7162, createdName=nakerunner, createdTime=Sat May 10 12:10:00 CST 2014, time=2014-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1910455, encodeId=dd8319104557d, content=<a href='/topic/show?id=faf7163606a' target=_blank style='color:#2F92EE;'>#SIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16360, encryptionId=faf7163606a, topicName=SIT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Fri Feb 07 18:10:00 CST 2014, time=2014-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1722977, encodeId=02711e22977ca, content=<a href='/topic/show?id=a43d39e48d' target=_blank style='color:#2F92EE;'>#CAFS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3974, encryptionId=a43d39e48d, topicName=CAFS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c42133335789, createdName=wleon8906, createdTime=Tue Mar 18 06:10:00 CST 2014, time=2014-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421572, encodeId=69a414215e2e8, content=<a href='/topic/show?id=4bc865819d2' target=_blank style='color:#2F92EE;'>#消融#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65819, encryptionId=4bc865819d2, topicName=消融)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a193676008, createdName=xiangyuzhou972, createdTime=Sat Aug 03 02:10:00 CST 2013, time=2013-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597706, encodeId=00d3159e706db, content=<a href='/topic/show?id=28986582e02' target=_blank style='color:#2F92EE;'>#消融治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65827, encryptionId=28986582e02, topicName=消融治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f07818523366, createdName=zhishijing, createdTime=Sat Aug 03 02:10:00 CST 2013, time=2013-08-03, status=1, ipAttribution=)]
    2014-05-10 nakerunner
  5. [GetPortalCommentsPageByObjectIdResponse(id=1738453, encodeId=63931e38453d5, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4763, encryptionId=a9dd4e63c4, topicName=CIT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eabf34462441, createdName=12498877m109暂无昵称, createdTime=Tue Apr 15 15:10:00 CST 2014, time=2014-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2007548, encodeId=3b1c200e548cf, content=<a href='/topic/show?id=930139e38e' target=_blank style='color:#2F92EE;'>#CAF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3973, encryptionId=930139e38e, topicName=CAF)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Tue Oct 01 09:10:00 CST 2013, time=2013-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1922517, encodeId=73bb192251ecb, content=<a href='/topic/show?id=3f3156324ff' target=_blank style='color:#2F92EE;'>#持续性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56324, encryptionId=3f3156324ff, topicName=持续性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c31495, createdName=liuyg0228, createdTime=Mon Jan 13 00:10:00 CST 2014, time=2014-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941525, encodeId=62f71941525ed, content=<a href='/topic/show?id=64c94e75a3' target=_blank style='color:#2F92EE;'>#City#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4775, encryptionId=64c94e75a3, topicName=City)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cd7162, createdName=nakerunner, createdTime=Sat May 10 12:10:00 CST 2014, time=2014-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1910455, encodeId=dd8319104557d, content=<a href='/topic/show?id=faf7163606a' target=_blank style='color:#2F92EE;'>#SIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16360, encryptionId=faf7163606a, topicName=SIT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Fri Feb 07 18:10:00 CST 2014, time=2014-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1722977, encodeId=02711e22977ca, content=<a href='/topic/show?id=a43d39e48d' target=_blank style='color:#2F92EE;'>#CAFS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3974, encryptionId=a43d39e48d, topicName=CAFS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c42133335789, createdName=wleon8906, createdTime=Tue Mar 18 06:10:00 CST 2014, time=2014-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421572, encodeId=69a414215e2e8, content=<a href='/topic/show?id=4bc865819d2' target=_blank style='color:#2F92EE;'>#消融#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65819, encryptionId=4bc865819d2, topicName=消融)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a193676008, createdName=xiangyuzhou972, createdTime=Sat Aug 03 02:10:00 CST 2013, time=2013-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597706, encodeId=00d3159e706db, content=<a href='/topic/show?id=28986582e02' target=_blank style='color:#2F92EE;'>#消融治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65827, encryptionId=28986582e02, topicName=消融治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f07818523366, createdName=zhishijing, createdTime=Sat Aug 03 02:10:00 CST 2013, time=2013-08-03, status=1, ipAttribution=)]
    2014-02-07 智慧医人
  6. [GetPortalCommentsPageByObjectIdResponse(id=1738453, encodeId=63931e38453d5, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4763, encryptionId=a9dd4e63c4, topicName=CIT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eabf34462441, createdName=12498877m109暂无昵称, createdTime=Tue Apr 15 15:10:00 CST 2014, time=2014-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2007548, encodeId=3b1c200e548cf, content=<a href='/topic/show?id=930139e38e' target=_blank style='color:#2F92EE;'>#CAF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3973, encryptionId=930139e38e, topicName=CAF)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Tue Oct 01 09:10:00 CST 2013, time=2013-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1922517, encodeId=73bb192251ecb, content=<a href='/topic/show?id=3f3156324ff' target=_blank style='color:#2F92EE;'>#持续性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56324, encryptionId=3f3156324ff, topicName=持续性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c31495, createdName=liuyg0228, createdTime=Mon Jan 13 00:10:00 CST 2014, time=2014-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941525, encodeId=62f71941525ed, content=<a href='/topic/show?id=64c94e75a3' target=_blank style='color:#2F92EE;'>#City#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4775, encryptionId=64c94e75a3, topicName=City)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cd7162, createdName=nakerunner, createdTime=Sat May 10 12:10:00 CST 2014, time=2014-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1910455, encodeId=dd8319104557d, content=<a href='/topic/show?id=faf7163606a' target=_blank style='color:#2F92EE;'>#SIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16360, encryptionId=faf7163606a, topicName=SIT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Fri Feb 07 18:10:00 CST 2014, time=2014-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1722977, encodeId=02711e22977ca, content=<a href='/topic/show?id=a43d39e48d' target=_blank style='color:#2F92EE;'>#CAFS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3974, encryptionId=a43d39e48d, topicName=CAFS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c42133335789, createdName=wleon8906, createdTime=Tue Mar 18 06:10:00 CST 2014, time=2014-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421572, encodeId=69a414215e2e8, content=<a href='/topic/show?id=4bc865819d2' target=_blank style='color:#2F92EE;'>#消融#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65819, encryptionId=4bc865819d2, topicName=消融)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a193676008, createdName=xiangyuzhou972, createdTime=Sat Aug 03 02:10:00 CST 2013, time=2013-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597706, encodeId=00d3159e706db, content=<a href='/topic/show?id=28986582e02' target=_blank style='color:#2F92EE;'>#消融治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65827, encryptionId=28986582e02, topicName=消融治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f07818523366, createdName=zhishijing, createdTime=Sat Aug 03 02:10:00 CST 2013, time=2013-08-03, status=1, ipAttribution=)]
    2014-03-18 wleon8906
  7. [GetPortalCommentsPageByObjectIdResponse(id=1738453, encodeId=63931e38453d5, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4763, encryptionId=a9dd4e63c4, topicName=CIT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eabf34462441, createdName=12498877m109暂无昵称, createdTime=Tue Apr 15 15:10:00 CST 2014, time=2014-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2007548, encodeId=3b1c200e548cf, content=<a href='/topic/show?id=930139e38e' target=_blank style='color:#2F92EE;'>#CAF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3973, encryptionId=930139e38e, topicName=CAF)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Tue Oct 01 09:10:00 CST 2013, time=2013-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1922517, encodeId=73bb192251ecb, content=<a href='/topic/show?id=3f3156324ff' target=_blank style='color:#2F92EE;'>#持续性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56324, encryptionId=3f3156324ff, topicName=持续性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c31495, createdName=liuyg0228, createdTime=Mon Jan 13 00:10:00 CST 2014, time=2014-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941525, encodeId=62f71941525ed, content=<a href='/topic/show?id=64c94e75a3' target=_blank style='color:#2F92EE;'>#City#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4775, encryptionId=64c94e75a3, topicName=City)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cd7162, createdName=nakerunner, createdTime=Sat May 10 12:10:00 CST 2014, time=2014-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1910455, encodeId=dd8319104557d, content=<a href='/topic/show?id=faf7163606a' target=_blank style='color:#2F92EE;'>#SIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16360, encryptionId=faf7163606a, topicName=SIT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Fri Feb 07 18:10:00 CST 2014, time=2014-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1722977, encodeId=02711e22977ca, content=<a href='/topic/show?id=a43d39e48d' target=_blank style='color:#2F92EE;'>#CAFS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3974, encryptionId=a43d39e48d, topicName=CAFS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c42133335789, createdName=wleon8906, createdTime=Tue Mar 18 06:10:00 CST 2014, time=2014-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421572, encodeId=69a414215e2e8, content=<a href='/topic/show?id=4bc865819d2' target=_blank style='color:#2F92EE;'>#消融#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65819, encryptionId=4bc865819d2, topicName=消融)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a193676008, createdName=xiangyuzhou972, createdTime=Sat Aug 03 02:10:00 CST 2013, time=2013-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597706, encodeId=00d3159e706db, content=<a href='/topic/show?id=28986582e02' target=_blank style='color:#2F92EE;'>#消融治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65827, encryptionId=28986582e02, topicName=消融治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f07818523366, createdName=zhishijing, createdTime=Sat Aug 03 02:10:00 CST 2013, time=2013-08-03, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1738453, encodeId=63931e38453d5, content=<a href='/topic/show?id=a9dd4e63c4' target=_blank style='color:#2F92EE;'>#CIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4763, encryptionId=a9dd4e63c4, topicName=CIT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eabf34462441, createdName=12498877m109暂无昵称, createdTime=Tue Apr 15 15:10:00 CST 2014, time=2014-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2007548, encodeId=3b1c200e548cf, content=<a href='/topic/show?id=930139e38e' target=_blank style='color:#2F92EE;'>#CAF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3973, encryptionId=930139e38e, topicName=CAF)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Tue Oct 01 09:10:00 CST 2013, time=2013-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1922517, encodeId=73bb192251ecb, content=<a href='/topic/show?id=3f3156324ff' target=_blank style='color:#2F92EE;'>#持续性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56324, encryptionId=3f3156324ff, topicName=持续性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c31495, createdName=liuyg0228, createdTime=Mon Jan 13 00:10:00 CST 2014, time=2014-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941525, encodeId=62f71941525ed, content=<a href='/topic/show?id=64c94e75a3' target=_blank style='color:#2F92EE;'>#City#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4775, encryptionId=64c94e75a3, topicName=City)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cd7162, createdName=nakerunner, createdTime=Sat May 10 12:10:00 CST 2014, time=2014-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1910455, encodeId=dd8319104557d, content=<a href='/topic/show?id=faf7163606a' target=_blank style='color:#2F92EE;'>#SIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16360, encryptionId=faf7163606a, topicName=SIT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Fri Feb 07 18:10:00 CST 2014, time=2014-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1722977, encodeId=02711e22977ca, content=<a href='/topic/show?id=a43d39e48d' target=_blank style='color:#2F92EE;'>#CAFS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3974, encryptionId=a43d39e48d, topicName=CAFS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c42133335789, createdName=wleon8906, createdTime=Tue Mar 18 06:10:00 CST 2014, time=2014-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421572, encodeId=69a414215e2e8, content=<a href='/topic/show?id=4bc865819d2' target=_blank style='color:#2F92EE;'>#消融#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65819, encryptionId=4bc865819d2, topicName=消融)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a193676008, createdName=xiangyuzhou972, createdTime=Sat Aug 03 02:10:00 CST 2013, time=2013-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597706, encodeId=00d3159e706db, content=<a href='/topic/show?id=28986582e02' target=_blank style='color:#2F92EE;'>#消融治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65827, encryptionId=28986582e02, topicName=消融治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f07818523366, createdName=zhishijing, createdTime=Sat Aug 03 02:10:00 CST 2013, time=2013-08-03, status=1, ipAttribution=)]